SHUAA Partners Acquisition Corp I: Nasdaq/NYSE listing notice — SHUAA Partners receives Nasdaq deficiency notice for insufficient shareholders; transfer to Capital Market approved

SHUAA Partners Acquisition Corp I

Received Nasdaq notice on May 17, 2023 for failing to meet minimum 400 total shareholders under Listing Rule 5450(a)(2).
Company has 45 days, until July 3, 2023, to submit a plan to regain compliance; no assurance Nasdaq will accept.
Transfer from Nasdaq Global Market to Nasdaq Capital Market approved, effective May 24, 2023; tickers unchanged (SHUA, SHUAU, SHUAW).
If compliance not regained, securities may be delisted; Company may appeal any rejection to a hearings panel.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

SHUAA Partners Acquisition Corp I received a nasdaq deficiency notice notice regarding other (rules 5450(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Rules: 5450(a)(2)

Exact text from the filing

May 17, 2023, SHUAA Partners Acquisition Corp I (the “Company”) received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because it does not have 400 or more shareholders, the Company is not in compliance with the total shareholder requirement for continued listing set forth in Nasdaq Listing Rule 5450(a)(2) (the “Rule”). Under the Nasdaq Listing Rules, the Company has 45 calendar days from receipt of the Notice, or until July 3, 2023, to submit a plan to regain compliance with the Rule. However, there can be no assurance that Nasdaq will accept

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001564590-23-007376

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.